XML 25 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net income $ 3,460 $ 9,500
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,283 5,055
Deferred income tax (benefit) expense (115) 385
Amortization of deferred costs 36 36
Compensation expense related to restricted stock awards 1,950 1,116
Provision for credit losses 983  
Loss on sale of assets, net 1,048 120
(Gain) on insurance claims (383)  
Other (gain), net (1,133) (119)
Barter (revenue) expense, net 89 50
Deferred and other compensation (230) (100)
Changes in assets and liabilities, net of business acquisition:    
Decrease (increase) in receivables and prepaid expenses 1,263 (1,303)
Increase in accounts payable, accrued expenses, and other liabilities 1,521 639
Total adjustments 10,312 5,879
Net cash provided by operating activities 13,772 15,379
Cash flows from investing activities:    
Purchase of short-term investments (19,660) (20,728)
Redemption of short-term investments 20,728 20,723
Acquisition of property and equipment (Capital Expenditures) (3,767) (4,356)
Acquisition of broadcast properties (5,711)  
Proceeds from sale and disposal of assets 203 1,747
Proceeds from redemption of investments and other 1,526  
Other investing activities (3) 117
Net cash used in investing activities (6,684) (2,497)
Cash flows from financing activities:    
Proceeds from long-term debt 5,000  
Cash dividends paid (22,520) (19,875)
Purchase of treasury shares (290) (227)
Net cash used in financing activities (17,810) (20,102)
Net decrease in cash and cash equivalents (10,722) (7,220)
Cash and cash equivalents, beginning of period 29,582 36,802
Cash and cash equivalents, end of period $ 18,860 $ 29,582